Amyl nitrite: Difference between revisions

Revision as of 23:08, 30 January 2014

Amyl nitrite
Amyl nitrite tablet^® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Description
Clinical Pharmacology
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]

For patient information, click here.

@@ Line 20: / Line 20: @@
 '''| [[Amyl nitrite adverse reactions|Adverse Reactions]]'''
 '''| [[Amyl nitrite drug interactions|Drug Interactions]]'''
-'''| [[Amyl nitrite use in specific populations|Use in Specific Populations]]'''
 '''| [[Amyl nitrite overdosage|Overdosage]]'''
 '''| [[Amyl nitrite description|Description]]'''
 '''| [[Amyl nitrite clinical pharmacology|Clinical Pharmacology]]'''
-'''| [[Amyl nitrite nonclinical toxicology|Nonclinical Toxicology]]'''
-'''| [[Amyl nitrite clinical studies|Clinical Studies]]'''
 '''| [[Amyl nitrite how supplied storage and handling|How Supplied/Storage and Handling]]'''
-'''| [[Amyl nitrite patient counseling information|Patient Counseling Information]]'''
 '''| [[Amyl nitrite labels and packages|Labels and Packages]]'''